Video News; Scythian Biosciences (TSX.V: $SCYB.V) Discusses
#Cannabinoid-based Treatment for #Concussion and Traumatic Brain Injury
August 18, 2017 – Investorideas.com, a
global news source and investor resource covering cannabis and biotech stocks
releases a video/ interview featuring David Schrader, Chief Operating Officer of
Scythian Biosciences (TSX.V:
SCYB), a company developing a drug regimen
for concussion and traumatic brain injury using a cannabinoid-based combination
drug therapy.
Scythian ( http://scythianbio.com/)
is a research and development company committed to finding a solution for the
prevention and treatment of concussions and traumatic brain injury with its
proprietary Cannabinoid combination.
Scythian's mission is to be the first
accepted drug regimen for concussive treatment. Scythian has recently formed a
collaboration with the University of Miami and its world renowned
neuroscientific team to conduct pre-clinical and clinical trials of its drug
regimen. The University of Miami
believes that Scythian's scientific approach shows significant promise and
differs from previous approaches to treat this growing problem. The collaboration with the University of
Miami allows access to their extensive knowledge base in the fields of
traumatic brain injury and concussions and allows for Scythian's clinical
studies to be undertaken at their world-class facilities.
Gillian A. Hotz, PhD, is leading Scythian's
program at the University of Miami. Dr.
Hotz is a nationally recognized behavioral neuroscientist and expert in
neurotrauma, concussion management, and neurorehabilitation. She has extensive experience in
neurocognitive testing. Dr. Hotz has
been the co-director of University of Miami Miller School of Medicine's
Concussion Program since 1995.
Scythian is also endorsed by Pro Football
Legends and the World Boxing Association on its mission.
About Investorideas.com - News that
Inspires Big Ideas
www.Investorideas.com is a meeting place for global
investors, featuring news, stock directories, video, podcasts, company profiles, interviews and more in leading
sectors.
The Investorideas.com podcasts are also
available on iTunes, Tunein, Sticher. Spreaker.com, iHeart.com and Google Play Music.
Subscribe
to Investorideas.com Podcast RSS:
Disclaimer/Disclosure: Investorideas.com is
a digital publisher of third party sourced news, articles and equity research
as well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. More disclaimer info:
http://www.investorideas.com/About/Disclaimer.asp.
Scythian Biosciences Corp. (SCYB) is a paid
featured company on the 420 Cannabis Investor Ideas Directory and is a paid
featured cannabis company and biotech for news, social media and PR effective
August 7th for 2 months. More details - http://www.investorideas.com/About/News/Clientspecifics.asp
Contact
Investorideas.com
800-665-0411
